Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02813421 · ClinicalTrials.gov registry record · NA
Continue Glucose Monitoring Before Insulin Pump
A NA study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02813421 is a NA study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 11 participants.
The verdict
NCT02813421, a NA study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of the study is to learn more about blood glucose control when people with Type 1 Diabetes switch to an insulin pump. The investigators hope to learn whether using a continuous glucose monitor (CGM) helps to create personalized insulin doses that may lead to stable blood glucoses and less frequent insulin pump dose changes during the transition to an insulin pump.
Interventions
- DEVICE CGM Informed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02813421
The ClinicalTrials.gov registry entry for NCT02813421 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CGM Informed is the first listed.
NCT02813421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02813421 about?
NCT02813421 is a clinical study titled "Continue Glucose Monitoring Before Insulin Pump". The purpose of the study is to learn more about blood glucose control when people with Type 1 Diabetes switch to an insulin pump. The investigators hope to learn whether using a continuous glucose monitor (CGM) helps to create personalized insulin doses that may lead to stable blood glucoses and les...
What is the current status of trial NCT02813421?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2016-03. Estimated completion is 2017-05-01.
What interventions are being tested in trial NCT02813421?
The interventions under investigation include: CGM Informed (DEVICE).
Who is sponsoring clinical trial NCT02813421?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.